Mr Davis joins Tryton Medical after a successful 20-year career with Guidant and Eli Lilly & Company. Most recently he was president of Guidant, Japan with profit and loss responsibility for the company’s $225 million cardiovascular business. Prior to his work in Japan, Mr Davis managed Guidant’s product portfolio in 13 Asian countries.
Dan Cole, co-founder and board member of Tryton, said: “We are delighted to welcome Greg to Tryton Medical during this pivotal time in the company’s development. We believe his proven track record of growing successful businesses and achieving results will enable Tryton to capitalize on its leadership position in the industry.”